New podcast episode – In conversation with Professor Charles Rice at the 75th Lindau Nobel Laureate Meeting

This article is 280 words and a one-minute read.

“When you give it your best shot and you think you overcome this barrier and you haven’t. You just have to say, well, damn it, I’m going to do it anyway or die trying.”

It’s not often you get to hear a conversation between a scientist at the start of their career and a scientist who has been awarded a Nobel Prize.

In this episode, Dr. Carina Vieira (University of Porto) interviews Nobel Laureate Professor Charles Rice (The Rockefeller University). Their discussion explores the value of the Lindau Nobel Laureate Meeting and key elements of Charles’ career.

Charles received the 2020 Nobel Prize in Physiology or Medicine for work focused on conducting the basic science to discover the hepatitis C virus (HCV), his team’s study of the HCV genome and constructing the first infectious clone of HCV that has led to the development of highly successful treatments of the virus.

Carina is a researcher at the Pharmaceutical Sciences department at the University of Porto. She joined hundreds of promising early-career scientists at the 75th Lindau Nobel Laureate Meeting that took place from 28 June to 3 July in Germany. BBMRI-ERIC sponsored Carina’s participation in the meeting as part of our commitment to supporting emerging talent and ideas driving future scientific breakthroughs.

The conversation took place directly after a BBMRI-ERIC panel on ‘The Role of International Infrastructure in Fostering One Health Through Big Data and AI’. Both Charles and Carina participated as panellists.

Listen to the full episode and hear Charles’ reflections on the value of persistence and what he believes is the greatest benefit of the Lindau experience: the connections formed between scientists from around the world.

BBMRI-ERIC Podcast

“In a changing world where we have so many challenges, we need to learn to listen to other disciplines and to move forward together…that is important to create impact.”

Welcome to the third, and last, episode related to BBMRI at the 75th Lindau Nobel Laureate Meeting that took place from 28 June to 3 July in Germany.

You’ll meet Professor Andrea Winkler who shares her expertise in One Health to bring a deeper understanding of the concept. At Lindau, BBMRI-ERIC hosted a panel session to discuss ‘The Role of International Infrastructure in Fostering One Health Through Big Data and AI’.

Professor Winkler took part in the panel that was a prime opportunity to address with young scientists how large infrastructures, like BBMRI with its focus on biobanking and sensitive health data, can play a major role in One Health datasets and research.

Andrea is a neuroscientist and a specialist neurologist, at TUM University Hospital, and the co(joint)-Director of the Center for Global Health at the School of Medicine and Health, at the Technical University of Munich (TUM), Germany.

Her special academic interests lie with Global Health, Global Brain Health and One Health and their application to different fields. She also co-chair’s The Lancet One Health Commission.

Read more: